Table 4 of Mykkänen, Mol Vis 2012; 18:2338-2351.
Description of group | Pathway | Genes1 | Z-score2 |
---|---|---|---|
HDF vs NCD | Systemic lupus erythematosus | 15 | 11.84 |
Type II diabetes mellitus | 3 | 3,87 | |
Allograft rejection | 3 | 3,50 | |
Graft-versus-host disease | 3 | 3.5 | |
Type I diabetes mellitus | 3 | 3.24 | |
Amoebiasis | 4 | 2.91 | |
Antigen processing and presentation | 3 | 2.81 | |
Apoptosis | 3 | 2,44 | |
Cell adhesion molecules (CAMs) | 4 | 2,40 | |
HFD+BB vs NCD | Systemic lupus erythematosus | 14 | 10.85 |
Protein processing in ER | 5 | 3.06 | |
MAPK signaling pathway | 6 | 2.38 | |
Wnt signaling pathway | 4 | 2.19 | |
NCD+BB vs NCD | Systemic lupus erythematosus | 14 | 9.62 |
Dilated cardiomyopathy | 3 | 2.1 | |
HFD+BB vs HFD | Systemic lupus erythematosus | 16 | 11.4 |
Tyrosine metabolism | 3 | 3.99 |